Vineet R. Jindal - Dec 10, 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role: Chief Financial Officer
Signature: /s/ Vineet R. Jindal
Stock symbol: RPHM
Transactions as of: Dec 10, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/14/2021, 03:32 PM
Previous filing: Aug 26, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPHM	Common Stock	Award	$0	+30K	+454.55%	$0.00	36.6K	Dec 10, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPHM	Stock option (right to buy)	Award	$0	+100K		$0.00	100K	Dec 10, 2021	Common Stock	100K	$6.69	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award.
F2	Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2021.
F3	The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.